← The Wire
ENTXNasdaq
Entera Bio Ltd.
Biological Products, (No Diagnostic Substances) · L3 · CIK 1638097
Develops first-in-class oral tablet peptide therapies for chronic conditions
$61M
Market cap
$1.65
Last close
+1.2%
1D
+11.5%
5D
474K
Volume
Price · last 39 sessions+48.6%
May 4L $1.11 · H $1.65Jun 29
161
Total filings
Jun 3, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AJun 3, 2026DEF 14ADEF 14AJun 3, 202610-Q10-QMay 8, 20268-KResults of Operations · Reg FD DisclosureMay 8, 20268-KMaterial Agreement · Equity IssuanceApr 3, 202610-K10-KMar 27, 20268-KResults of Operations · Reg FD DisclosureMar 27, 20268-KReg FD DisclosureMar 4, 20268-KExecutive Change · Reg FD DisclosureFeb 9, 20268-KExecutive Change · Material AgreementFeb 4, 202610-Q10-QNov 14, 20258-KResults of Operations · Reg FD DisclosureNov 14, 202510-Q10-QAug 8, 20258-KResults of Operations · Reg FD DisclosureAug 8, 20258-KReg FD Disclosure · Company UpdateJul 28, 20258-KShareholder VoteJul 18, 2025DEFA14ADEFA 14AJun 5, 2025DEF 14ADEF 14AJun 5, 202510-Q10-QMay 9, 20258-KResults of Operations · Reg FD DisclosureMay 9, 202510-K10-KMar 28, 20258-KResults of Operations · Reg FD DisclosureMar 28, 20258-KMaterial Agreement · Equity IssuanceMar 17, 20258-KCompany UpdateJan 10, 2025424B5424B5Jan 10, 20258-K/AShareholder VoteDec 20, 202410-Q10-QNov 8, 20248-KResults of Operations · Reg FD DisclosureNov 8, 202410-Q10-QAug 9, 20248-KResults of Operations · Reg FD DisclosureAug 9, 20248-KShareholder VoteAug 2, 2024DEFA14ADEFA14AJun 20, 2024DEF 14ADEF 14AJun 20, 202410-Q10-QMay 10, 20248-KResults of Operations · Reg FD DisclosureMay 10, 202410-K10-KMar 8, 20248-KResults of Operations · Reg FD DisclosureMar 8, 20248-KReg FD DisclosureMar 4, 20248-KReg FD DisclosureFeb 2, 20248-KCompany UpdateJan 3, 20248-KMaterial Agreement · Equity IssuanceDec 26, 202310-Q10-QNov 14, 20238-KResults of Operations · Reg FD DisclosureNov 14, 20238-KShareholder VoteSep 13, 2023DEF 14ADEF 14AAug 15, 202310-Q10-QAug 11, 20238-KResults of Operations · Reg FD DisclosureAug 11, 20238-KDelisting NoticeJun 30, 20238-KCompany UpdateJun 27, 20238-KExecutive ChangeJun 7, 202310-Q10-QMay 5, 20238-KResults of Operations · Reg FD DisclosureMay 5, 202310-K10-KMar 31, 20238-KResults of Operations · Reg FD DisclosureMar 31, 20238-KDelisting NoticeNov 23, 202210-Q10-QNov 10, 20228-KResults of Operations · Reg FD DisclosureNov 10, 20228-KCompany UpdateOct 6, 20228-KShareholder VoteSep 9, 2022424B54245B5Sep 2, 20228-KMaterial Agreement · Company UpdateSep 2, 202210-Q10-QAug 11, 20228-KResults of Operations · Reg FD DisclosureAug 11, 20228-KReg FD DisclosureAug 1, 2022DEF 14ADEF 14AJul 29, 20228-KExecutive ChangeJul 18, 20228-KExecutive ChangeJun 17, 20228-KMaterial AgreementMay 27, 20228-KExecutive ChangeMay 16, 202210-Q10-QMay 12, 20228-KResults of Operations · Reg FD DisclosureMay 12, 202210-K/A10-K/AApr 29, 202210-K10-KMar 8, 20228-KResults of Operations · Reg FD DisclosureMar 8, 20226-K6-KNov 10, 20216-K6-KNov 10, 20216-K6-KOct 28, 20216-K6-KOct 14, 20216-K6-KOct 6, 20216-K6-KSep 1, 2021
Insider Activity
◆ Cluster Buy · 5 insidersIn the 90 days to Mar 9, 2026: 5 insiders bought $141K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 9, 2026 | Germano Geno JDirector | Buy | 20,000 | $1.30 | $26K |
| Mar 5, 2026 | Ellis SeanDirector | Buy | 10,000 | $1.23 | $12K |
| Feb 12, 2026 | Rubin Steven DDirector | Buy | 5,000 | $1.49 | $7K |
| Feb 10, 2026 | Germano Geno JDirector | Buy | 20,000 | $1.49 | $30K |
| Feb 10, 2026 | Taitel HayaDirector | Buy | 7,500 | $1.48 | $11K |
| Feb 9, 2026 | Ellis SeanDirector | Buy | 18,000 | $1.24 | $22K |
| Feb 9, 2026 | Rubin Steven DDirector | Buy | 10,000 | $1.20 | $12K |
| Dec 29, 2025 | Toledano Miranda JayneChief Executive Officer | Buy | 11,000 | $1.81 | $20K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance